Annual report
9438.TEDINET S100PV9Y
Period2021-10-01 → 2022-09-30
Filed2022-12-26
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 155
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥26.5bn | 2021-10-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥25.7bn | 2020-10-01 → 2021-09-30 | Cons. | Net sales |
| Revenue | ¥26.1bn | 2019-10-01 → 2020-09-30d | Cons. | Net sales (5-year summary) |
| Revenue | ¥27.1bn | 2018-10-01 → 2019-09-30d | Cons. | Net sales (5-year summary) |
| Revenue | ¥29.1bn | 2017-10-01 → 2018-09-30d | Cons. | Net sales (5-year summary) |
| Operating income | ¥871m | 2021-10-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | ¥1.9bn | 2020-10-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | ¥486m | 2021-10-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥1.4bn | 2020-10-01 → 2021-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥2.1bn | 2019-10-01 → 2020-09-30d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥3.1bn | 2018-10-01 → 2019-09-30d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥3.1bn | 2017-10-01 → 2018-09-30d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | −¥305m | 2021-10-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥986m | 2020-10-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥930m | 2021-10-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥1.2bn | 2020-10-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥507m | 2019-10-01 → 2020-09-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.5bn | 2018-10-01 → 2019-09-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.6bn | 2017-10-01 → 2018-09-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | −¥1.1bn | 2021-10-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | −¥1.5bn | 2020-10-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥29.3bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥31.9bn | at 2021-09-30 | Cons. | Assets |
| Total assets | ¥30.5bn | at 2020-09-30d | Cons. | Total assets (5-year summary) |
| Total assets | ¥27.5bn | at 2019-09-30d | Cons. | Total assets (5-year summary) |
| Total assets | ¥23.9bn | at 2018-09-30d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥11.4bn | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥10.7bn | at 2021-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥17.9bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥21.2bn | at 2021-09-30 | Cons. | Net assets |
| Net assets / equity | ¥21.5bn | at 2020-09-30d | Cons. | Net assets |
| Net assets / equity | ¥21.8bn | at 2019-09-30d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥18.8bn | at 2018-09-30d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥12.1bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥15.5bn | at 2021-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥12.1bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥15.5bn | at 2021-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥13.4bn | at 2020-09-30d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥12.4bn | at 2019-09-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥10.5bn | at 2018-09-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | −¥1.4bn | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥3.5bn | 2020-10-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥3.3bn | 2019-10-01 → 2020-09-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥4.0bn | 2018-10-01 → 2019-09-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥4.5bn | 2017-10-01 → 2018-09-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥2.5bn | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.0bn | 2020-10-01 → 2021-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥4.8bn | 2019-10-01 → 2020-09-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥3.6bn | 2018-10-01 → 2019-09-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥3.3bn | 2017-10-01 → 2018-09-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥344m | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥649m | 2020-10-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥2.4bn | 2019-10-01 → 2020-09-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥1.5bn | 2018-10-01 → 2019-09-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥855m | 2017-10-01 → 2018-09-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥-16.99 | 2021-10-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-21.28 | 2020-10-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥9.28 | 2019-10-01 → 2020-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥27.59 | 2018-10-01 → 2019-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥29.85 | 2017-10-01 → 2018-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥9.27 | 2019-10-01 → 2020-09-30d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥27.56 | 2018-10-01 → 2019-09-30d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥29.75 | 2017-10-01 → 2018-09-30d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥256.61 | at 2022-09-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥318.29 | at 2021-09-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥350.83 | at 2020-09-30d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥363.53 | at 2019-09-30d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥328.78 | at 2018-09-30d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 48.1% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.6% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 62.7% | at 2020-09-30d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 72.3% | at 2019-09-30d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 75.2% | at 2018-09-30d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | -5.9% | 2021-10-01 → 2022-09-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | -6.4% | 2020-10-01 → 2021-09-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 2.6% | 2019-10-01 → 2020-09-30d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 8.0% | 2018-10-01 → 2019-09-30d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 9.3% | 2017-10-01 → 2018-09-30d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 1,316 | at 2022-09-30 | Cons. | Number of employees |
| Employees | 1,295 | at 2021-09-30 | Cons. | Number of employees |
| Employees | 1,194 | at 2020-09-30d | Cons. | Number of employees |
| Employees | 1,136 | at 2019-09-30d | Cons. | Number of employees |
| Employees | 1,055 | at 2018-09-30d | Cons. | Number of employees |
| Revenue | ¥21.4bn | 2021-10-01 → 2022-09-30 | Standalone | Net sales |
| Revenue | ¥20.7bn | 2020-10-01 → 2021-09-30 | Standalone | Net sales |
| Revenue | ¥20.9bn | 2019-10-01 → 2020-09-30d | Standalone | Net sales (5-year summary) |
| Revenue | ¥21.8bn | 2018-10-01 → 2019-09-30d | Standalone | Net sales (5-year summary) |
| Revenue | ¥24.9bn | 2017-10-01 → 2018-09-30d | Standalone | Net sales (5-year summary) |
| Operating income | ¥2.9bn | 2021-10-01 → 2022-09-30 | Standalone | Operating income |
| Operating income | ¥2.4bn | 2020-10-01 → 2021-09-30 | Standalone | Operating income |
| Ordinary income | ¥1.3bn | 2021-10-01 → 2022-09-30 | Standalone | Ordinary income |
| Ordinary income | ¥2.3bn | 2020-10-01 → 2021-09-30 | Standalone | Ordinary income |
| Ordinary income | ¥3.5bn | 2019-10-01 → 2020-09-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.8bn | 2018-10-01 → 2019-09-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥3.5bn | 2017-10-01 → 2018-09-30d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | −¥3.2bn | 2021-10-01 → 2022-09-30 | Standalone | Income before income taxes |
| Profit before tax | ¥7.3bn | 2020-10-01 → 2021-09-30 | Standalone | Income before income taxes |
| Net income | −¥3.5bn | 2021-10-01 → 2022-09-30 | Standalone | Profit loss |
| Net income | ¥5.0bn | 2020-10-01 → 2021-09-30 | Standalone | Profit loss |
| Net income | ¥1.0bn | 2019-10-01 → 2020-09-30d | Standalone | Net income loss (5-year summary) |
| Net income | ¥12m | 2018-10-01 → 2019-09-30d | Standalone | Net income loss (5-year summary) |
| Net income | ¥1.3bn | 2017-10-01 → 2018-09-30d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥25.0bn | at 2022-09-30 | Standalone | Assets |
| Total assets | ¥30.3bn | at 2021-09-30 | Standalone | Assets |
| Total assets | ¥24.8bn | at 2020-09-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥21.5bn | at 2019-09-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥21.8bn | at 2018-09-30d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥10.0bn | at 2022-09-30 | Standalone | Liabilities |
| Total liabilities | ¥9.5bn | at 2021-09-30 | Standalone | Liabilities |
| Net assets / equity | ¥15.0bn | at 2022-09-30 | Standalone | Net assets |
| Net assets / equity | ¥20.9bn | at 2021-09-30 | Standalone | Net assets |
| Net assets / equity | ¥16.6bn | at 2020-09-30d | Standalone | Net assets |
| Net assets / equity | ¥16.8bn | at 2019-09-30d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥17.3bn | at 2018-09-30d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥6.5bn | at 2022-09-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥10.0bn | at 2021-09-30 | Standalone | Cash and deposits |
| EPS (basic) | ¥-64.1 | 2021-10-01 → 2022-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥90.56 | 2020-10-01 → 2021-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥18.43 | 2019-10-01 → 2020-09-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥0.21 | 2018-10-01 → 2019-09-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥23.99 | 2017-10-01 → 2018-09-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥90.26 | 2020-10-01 → 2021-09-30 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥18.42 | 2019-10-01 → 2020-09-30d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥0.21 | 2018-10-01 → 2019-09-30d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥23.9 | 2017-10-01 → 2018-09-30d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥16 | 2021-10-01 → 2022-09-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥16 | 2020-10-01 → 2021-09-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥16 | 2019-10-01 → 2020-09-30d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥16 | 2018-10-01 → 2019-09-30d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥16 | 2017-10-01 → 2018-09-30d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥271.45 | at 2022-09-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥377.02 | at 2021-09-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥299.23 | at 2020-09-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥301.78 | at 2019-09-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥313.1 | at 2018-09-30d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 59.6% | at 2022-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 68.3% | at 2021-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 66.1% | at 2020-09-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 76.8% | at 2019-09-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.7% | at 2018-09-30d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | -19.8% | 2021-10-01 → 2022-09-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 26.8% | 2020-10-01 → 2021-09-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.1% | 2019-10-01 → 2020-09-30d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 0.1% | 2018-10-01 → 2019-09-30d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.8% | 2017-10-01 → 2018-09-30d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 61,263,000 | at 2022-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 61,248,200 | at 2021-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 61,144,600 | at 2020-09-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 61,139,000 | at 2019-09-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 61,016,400 | at 2018-09-30d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 762 | at 2022-09-30 | Standalone | Number of employees |
| Employees | 757 | at 2021-09-30 | Standalone | Number of employees |
| Employees | 734 | at 2020-09-30d | Standalone | Number of employees |
| Employees | 716 | at 2019-09-30d | Standalone | Number of employees |
| Employees | 695 | at 2018-09-30d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 48
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | depreciation | 2021-10-01 → 2022-09-30 | ¥101m |
| Reconciling Itemsreconciling | revenue | 2021-10-01 → 2022-09-30 | −¥1.3bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-10-01 → 2022-09-30 | −¥1.3bn |
| Reconciling Itemsreconciling | segment profit | 2021-10-01 → 2022-09-30 | −¥2.6bn |
| Content Businessreportable segment | depreciation | 2021-10-01 → 2022-09-30 | ¥906m |
| Content Businessreportable segment | revenue | 2021-10-01 → 2022-09-30 | ¥18.5bn |
| Content Businessreportable segment | revenue external | 2021-10-01 → 2022-09-30 | ¥18.3bn |
| Content Businessreportable segment | revenue intersegment | 2021-10-01 → 2022-09-30 | ¥234m |
| Content Businessreportable segment | segment profit | 2021-10-01 → 2022-09-30 | ¥6.2bn |
| Healthcare Businessreportable segment | depreciation | 2021-10-01 → 2022-09-30 | ¥210m |
| Healthcare Businessreportable segment | revenue | 2021-10-01 → 2022-09-30 | ¥4.0bn |
| Healthcare Businessreportable segment | revenue external | 2021-10-01 → 2022-09-30 | ¥4.0bn |
| Healthcare Businessreportable segment | revenue intersegment | 2021-10-01 → 2022-09-30 | ¥16m |
| Healthcare Businessreportable segment | segment profit | 2021-10-01 → 2022-09-30 | −¥1.1bn |
| Other Businessreportable segment | depreciation | 2021-10-01 → 2022-09-30 | ¥277m |
| Other Businessreportable segment | revenue | 2021-10-01 → 2022-09-30 | ¥5.3bn |
| Other Businessreportable segment | revenue external | 2021-10-01 → 2022-09-30 | ¥4.2bn |
| Other Businessreportable segment | revenue intersegment | 2021-10-01 → 2022-09-30 | ¥1.1bn |
| Other Businessreportable segment | segment profit | 2021-10-01 → 2022-09-30 | −¥1.7bn |
| —segment total | depreciation | 2021-10-01 → 2022-09-30 | ¥1.4bn |
| —segment total | revenue | 2021-10-01 → 2022-09-30 | ¥27.8bn |
| —segment total | revenue external | 2021-10-01 → 2022-09-30 | ¥26.5bn |
| —segment total | revenue intersegment | 2021-10-01 → 2022-09-30 | ¥1.3bn |
| —segment total | segment profit | 2021-10-01 → 2022-09-30 | ¥3.4bn |
| Reconciling Itemsreconciling | depreciation | 2020-10-01 → 2021-09-30 | ¥119m |
| Reconciling Itemsreconciling | revenue | 2020-10-01 → 2021-09-30 | −¥1.2bn |
| Reconciling Itemsreconciling | revenue intersegment | 2020-10-01 → 2021-09-30 | −¥1.2bn |
| Reconciling Itemsreconciling | segment profit | 2020-10-01 → 2021-09-30 | −¥2.6bn |
| Content Businessreportable segment | depreciation | 2020-10-01 → 2021-09-30 | ¥731m |
| Content Businessreportable segment | revenue | 2020-10-01 → 2021-09-30 | ¥18.9bn |
| Content Businessreportable segment | revenue external | 2020-10-01 → 2021-09-30 | ¥18.7bn |
| Content Businessreportable segment | revenue intersegment | 2020-10-01 → 2021-09-30 | ¥177m |
| Content Businessreportable segment | segment profit | 2020-10-01 → 2021-09-30 | ¥5.9bn |
| Healthcare Businessreportable segment | depreciation | 2020-10-01 → 2021-09-30 | ¥276m |
| Healthcare Businessreportable segment | revenue | 2020-10-01 → 2021-09-30 | ¥3.8bn |
| Healthcare Businessreportable segment | revenue external | 2020-10-01 → 2021-09-30 | ¥3.6bn |
| Healthcare Businessreportable segment | revenue intersegment | 2020-10-01 → 2021-09-30 | ¥170m |
| Healthcare Businessreportable segment | segment profit | 2020-10-01 → 2021-09-30 | −¥1.3bn |
| Other Businessreportable segment | depreciation | 2020-10-01 → 2021-09-30 | ¥112m |
| Other Businessreportable segment | revenue | 2020-10-01 → 2021-09-30 | ¥4.4bn |
| Other Businessreportable segment | revenue external | 2020-10-01 → 2021-09-30 | ¥3.4bn |
| Other Businessreportable segment | revenue intersegment | 2020-10-01 → 2021-09-30 | ¥903m |
| Other Businessreportable segment | segment profit | 2020-10-01 → 2021-09-30 | −¥106m |
| —segment total | depreciation | 2020-10-01 → 2021-09-30 | ¥1.1bn |
| —segment total | revenue | 2020-10-01 → 2021-09-30 | ¥27.0bn |
| —segment total | revenue external | 2020-10-01 → 2021-09-30 | ¥25.7bn |
| —segment total | revenue intersegment | 2020-10-01 → 2021-09-30 | ¥1.2bn |
| —segment total | segment profit | 2020-10-01 → 2021-09-30 | ¥4.6bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,714
| Item | Context | Value | Unit |
|---|---|---|---|
| Average number of temporary workers | Prior2YearInstant_NonConsolidatedMember | 17 | |
| Average number of temporary workers | Prior1YearInstant_NonConsolidatedMember | 13 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember | 13 | |
| Total shareholder return | Prior4YearInstant_NonConsolidatedMember | 0.956 | |
| Total shareholder return | Prior3YearInstant_NonConsolidatedMember | 1.090 | |
| Total shareholder return | Prior2YearInstant_NonConsolidatedMember | 1.378 | |
| Total shareholder return | Prior1YearInstant_NonConsolidatedMember | 1.230 | |
| Total shareholder return | CurrentYearInstant_NonConsolidatedMember | 0.858 | |
| Total return on share price index | Prior4YearInstant_NonConsolidatedMember | 1.108 | |
| Total return on share price index | Prior3YearInstant_NonConsolidatedMember | 0.993 | |
| Total return on share price index | Prior2YearInstant_NonConsolidatedMember | 1.042 | |
| Total return on share price index | Prior1YearInstant_NonConsolidatedMember | 1.329 | |
| Total return on share price index | CurrentYearInstant_NonConsolidatedMember | 1.234 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E05049-000ContentBusinessMember | 377 | |
| Average number of temporary workers | CurrentYearInstant_jpcrp030000-asr_E05049-000ContentBusinessMember | 9 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E05049-000HealthcareBusinessMember | 247 | |
| Average number of temporary workers | CurrentYearInstant_jpcrp030000-asr_E05049-000HealthcareBusinessMember | 8 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E05049-000OtherBusinessMember | 422 | |
| Average number of temporary workers | CurrentYearInstant_jpcrp030000-asr_E05049-000OtherBusinessMember | 16 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E05049-000CompanyWideMember | 270 | |
| Average number of temporary workers | CurrentYearInstant_jpcrp030000-asr_E05049-000CompanyWideMember | 2 | |
| Number of employees | CurrentYearInstant | 1316 | |
| Average number of temporary workers | CurrentYearInstant | 35 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 762 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember | 13 | |
| Average age years information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 39.5 | |
| Average length of service years information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 8.5 | |
| Average annual salary information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 6419705 | JPY |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E05049-000ContentBusinessMember | 246 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E05049-000ContentBusinessMember | 7 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E05049-000HealthcareBusinessMember | 152 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E05049-000HealthcareBusinessMember | 3 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E05049-000OtherBusinessMember | 94 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E05049-000OtherBusinessMember | 1 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E05049-000CompanyWideMember | 270 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E05049-000CompanyWideMember | 2 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 762 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember | 13 | |
| Research and development expenses research and development activities | CurrentYearDuration | 73000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration | 2198000000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 61263000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 61263000 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 61263000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 61263000 | |
| Number of shares constituting one unit | CurrentYearInstant_OrdinaryShareMember | 100 | |
| Number of shareholders national and local governments | CurrentYearInstant_OrdinaryShareMember | 0 | |
| Number of shareholders financial institutions | CurrentYearInstant_OrdinaryShareMember | 10 | |
| Number of shareholders financial service providers | CurrentYearInstant_OrdinaryShareMember | 24 | |
| Number of shareholders other corporations | CurrentYearInstant_OrdinaryShareMember | 51 | |
| Number of shareholders foreign investors other than individuals | CurrentYearInstant_OrdinaryShareMember | 69 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |